Return to search

Effectiveness and safety of apixaban versus rivaroxaban in patients with nonvalvular atrial fibrillation and type 2 diabetes mellitus

No description available.
Identiferoai:union.ndltd.org:mcgill.ca/oai:escholarship.mcgill.ca:ks65hj13f
Date January 2022
CreatorsRoy Chowdhury, Krishna
ContributorsChristel Renoux (Supervisor1), Laurent Azoulay (Supervisor2)
PublisherMcGill University
Source SetsMcGill University
Languagehttp://id.loc.gov/vocabulary/iso639-2/eng
Detected LanguageEnglish
TypeThesis
RightsAll items in eScholarship@McGill are protected by copyright with all rights reserved unless otherwise indicated.

Page generated in 0.0014 seconds